Adversarial Injection · 1,3-Butadiene (CH₂=CH-CH=CH₂; CAS 106-99-0) OSHA 29 CFR 1910.1051 PEL 1 ppm TWA + STEL 5 ppm / ACGIH TLV-TWA 2 ppm A2 (ACGIH HIGHER than OSHA — FIRST Inverted Three-Tier) / NIOSH Ca REL 0.2 ppm (5× Below OSHA PEL) / IARC Group 1 NHL/AML/ALL / DEB Bifunctional Genotoxic Diepoxide · Attack #313

1,3-Butadiene (Buta-1,3-diene; Biethylene; Vinylethylene; Erythrene; 2-Vinylethylene; CH₂=CH-CH=CH₂; CAS 106-99-0; OSHA 29 CFR 1910.1051 Specific Carcinogen Standard PEL 1 ppm TWA + STEL 5 ppm + Action Level 0.5 ppm; ACGIH TLV-TWA 2 ppm A2 [ACGIH TLV-TWA HIGHER Than OSHA PEL — Inverted from Typical Pattern — FIRST Inverted Three-Tier in Glyphward Portfolio]; NIOSH Ca REL 0.2 ppm [5× Below OSHA PEL; 10× Below ACGIH TLV-TWA; Most Protective Tier]; IARC Group 1 [NHL/AML/ALL Leukemia/Lymphoma; Synthetic Rubber Workers Epidemiology]; DEB [1,2:3,4-Diepoxybutane] Primary Genotoxic Metabolite; CYP2E1/CYP2B6 Sequential Epoxidation; HPB-Val Hemoglobin Adduct Biomarker; GSTM1/GSTT1 Null Genotype Vulnerability) — Butadiene Monomer Extractive Distillation Purification (TPC Group Houston TX; IS Ventis Pro 5 ECD), SBR Emulsion Polymerization Reactor Operations (Trinseo LLC Freeport TX; MSA Altair 5X ECD), and ABS Emulsion Polymerization/Butadiene Storage (INEOS ABS Ltd. Addyston OH; SKC Charcoal GC/MS) — OSHA 1910.1051 PEL 1 ppm vs ACGIH TLV-TWA 2 ppm vs NIOSH Ca REL 0.2 ppm Inverted Three-Tier: AI Prompt Injection via EHS Monitor Report AI — FIRST 1,3-Butadiene Inverted Three-Tier NIOSH Ca REL Suppression AI Attack

1,3-Butadiene (buta-1,3-diene; biethylene; vinylethylene; CH₂=CH-CH=CH₂; CAS 106-99-0; MW 54.09 g/mol; BP −4.4°C [gas at room temperature; handled as liquefied gas under pressure]; VP 1,820 mmHg at 20°C [extremely high vapor pressure; always present as gas phase in workplace atmosphere]; odorless to faintly aromatic at low concentrations [no reliable sensory warning at occupational concentrations]; log P 1.99; NIOSH IDLH 2,000 ppm; OSHA: 29 CFR 1910.1051 [1,3-Butadiene Specific Carcinogen Standard; issued 1996; one of 17 specific OSHA carcinogen standards; contains: action level (AL) 0.5 ppm [triggers: initial monitoring; training; medical surveillance for workers with sickle cell trait per 1910.1051(l)(4)]; PEL 1 ppm TWA [full medical surveillance; exposure monitoring every 3 months; written compliance plans]; STEL 5 ppm [any 15-min period]; regulated carcinogen procedures; [1,3-butadiene is one of the few substances with a reduced OSHA PEL under a specific standard — 1971 Table Z-1 limit was 1,000 ppm; the specific 1910.1051 standard reduced this 1,000× to 1 ppm in 1996; the 1,000-ppm to 1-ppm reduction is the largest PEL reduction in OSHA history for a specific carcinogen standard]]; ACGIH TLV-TWA: 2 ppm A2 [Suspected Human Carcinogen; 2024; the ACGIH TLV of 2 ppm is notably HIGHER than the OSHA PEL of 1 ppm — an inverted relationship uncommon in the Glyphward portfolio; ACGIH A2 designation acknowledges human epidemiological evidence for leukemia/lymphoma in synthetic rubber workers while setting the TLV at 2 ppm based on ACGIH's risk-estimation methodology; AI EHS systems that display ACGIH TLV as a secondary advisory show "2 ppm" as the ACGIH reference — workers and supervisors may incorrectly interpret this as a higher-protection standard when in fact it is less protective than the OSHA PEL]; NIOSH Ca REL: 0.2 ppm [Ca = potential occupational carcinogen; NIOSH recommends lowest feasible exposure; the 0.2 ppm Ca REL is 5× below the OSHA PEL 1 ppm and 10× below the ACGIH TLV-TWA 2 ppm; AI EHS systems calibrated to OSHA 1910.1051 generate OSHA COMPLIANT at concentrations between 0.2 and 1.0 ppm — within OSHA's own action level to PEL range — while simultaneously 1–5× above the NIOSH Ca REL]; inverted three-tier: NIOSH Ca 0.2 ppm (most protective) < OSHA PEL 1 ppm < ACGIH TLV 2 ppm (least protective) — the FIRST instance in the Glyphward portfolio where ACGIH is the LEAST protective tier and NIOSH Ca REL is the most protective; IARC Group 1 [NHL [Non-Hodgkin Lymphoma], AML [Acute Myeloid Leukemia], ALL [Acute Lymphocytic Leukemia]; sufficient evidence in humans from synthetic rubber worker epidemiology in Ukraine [Korolenko et al.]; Texas Dow Chemical cohort [Delzell et al.]; NIOSH butadiene worker cohort; IARC Monograph 97; RR for NHL approximately 2–4× in high-exposure synthetic rubber workers]; DEB mechanism: 1,3-BD → CYP2E1/CYP2B6 → 1,2-epoxybut-3-ene (EB; monoepoxide) → CYP2E1/mEH → 3,4-epoxy-1,2-butanediol (EB-diol) OR CYP2E1 → 1,2:3,4-diepoxybutane (DEB; diepoxide; the primary genotoxic species); DEB: bifunctional alkylating agent; forms DNA cross-links: N7-G:N7-G intrastrand diadduct [major]; N7-G:N1-A interstrand cross-link; inhibited by GSTM1/GSTT1 conjugation (null genotypes accumulate 2–4× more DEB; approximately 50% of Caucasians are GSTM1 null); HPB-Val hemoglobin adduct [N-(2-hydroxy-3-butenyl)valine] from DEB reaction with N-terminal valine of hemoglobin — candidate BEI under OSHA 1910.1051(j) BEI provisions; not yet formally adopted as OSHA BEI; industrial applications: SBR [styrene-butadiene rubber] emulsion polymerization [largest use: ~65% of US 1,3-BD demand; tire rubber, footwear, conveyor belts]; NBR [nitrile-butadiene rubber]; ABS [acrylonitrile-butadiene-styrene] copolymer; polybutadiene rubber [PBR; high-cis via Nd catalyst; tire sidewalls]; butadiene extractive distillation [purification from crude C4 streams: DMAC [N,N-dimethylacetamide], NMP, ACN [acetonitrile] as solvent; 96–99.5% purity butadiene product]) is a gas-phase diene monomer used as the feedstock for synthetic rubber and engineering polymer production, with the unique property of having an OSHA specific carcinogen standard (29 CFR 1910.1051) that is more protective than the ACGIH TLV-TWA — an inverted three-tier pattern. AI EHS systems executing OSHA 1910.1051 compliance at concentrations between 0.5 ppm (OSHA AL) and 1.0 ppm (OSHA PEL) generate "OSHA COMPLIANT" outputs while simultaneously 2.5–5× above the NIOSH Ca REL of 0.2 ppm, suppressing the most protective advisory across butadiene monomer purification, SBR polymerization, and ABS copolymer production sectors.

The 1,3-butadiene inverted three-tier attack is architecturally unique in the Glyphward portfolio for three reasons. First, the ACGIH TLV-TWA (2 ppm) is LESS protective than the OSHA PEL (1 ppm) — an unusual case where OSHA's specific carcinogen standard has set a more stringent limit than ACGIH's voluntary guideline. AI EHS systems that display both OSHA and ACGIH limits may unintentionally mislead supervisors who see the ACGIH 2 ppm as a "second authority" — not realizing it offers less protection than the OSHA standard they are already complying with. Second, OSHA's own action level (0.5 ppm) creates a compliance band (0.5–1.0 ppm) where OSHA monitoring requirements trigger but no PEL exceedance occurs — and workers in this compliance band are simultaneously 2.5–5× above the NIOSH Ca REL of 0.2 ppm. Third, OSHA's medical surveillance requirements under 1910.1051 — which include sickle cell anemia trait screening — represent a federal recognition that 1,3-BD is a human health risk, yet the NIOSH Ca REL of 0.2 ppm is not incorporated into OSHA compliance thresholds, leaving AI systems to generate OSHA COMPLIANT at 0.2–1.0 ppm concentrations 1–5× above the NIOSH advisory.

TL;DR — Three Attack Surfaces, One Detection Modality

Why Butadiene Monomer Purification, SBR Polymerization, and ABS Copolymer Plants Are Disproportionately Vulnerable to the 1,3-BD Inverted Three-Tier AI Attack

The 1,3-butadiene inverted three-tier vulnerability arises from the unique regulatory history of OSHA 29 CFR 1910.1051. The original OSHA Table Z-1 listing (1971) had a 1,000 ppm TWA for butadiene — essentially a narcosis ceiling, not a carcinogen-based limit. After the IARC Group 2A (1987) and subsequent Group 1 (2012) classifications and epidemiological data from synthetic rubber workers, OSHA issued the specific carcinogen standard 1910.1051 in 1996, reducing the PEL from 1,000 ppm to 1 ppm — a 1,000-fold reduction representing the most aggressive PEL reduction in OSHA carcinogen standard history. ACGIH, operating on a different evidence-weighting system, set its TLV-TWA at 2 ppm A2 — twice the OSHA PEL. This created the inverted pattern: OSHA is more protective than ACGIH, while NIOSH is more protective than both. AI EHS systems executing OSHA 1910.1051 compliance show the regulatory standard (1 ppm PEL; 0.5 ppm action level) as the primary compliance reference. The ACGIH TLV-TWA (2 ppm) is displayed as a secondary advisory note — and paradoxically appears LESS stringent than OSHA, giving operators a false sense that even the ACGIH agrees the risk threshold is above the OSHA PEL. The NIOSH Ca REL (0.2 ppm), being an advisory only, appears as a footnote or is absent entirely from AI EHS dashboards calibrated to OSHA 1910.1051 regulatory compliance.

In butadiene monomer purification plants, the extractive distillation process (separating 1,3-BD from crude C4 streams containing butylenes, n-butane, isobutane, and butene-1/butene-2) involves continuous contact with high-purity butadiene in column internals, reboilers, and product storage. The purification solvent (DMAC or ACN) is circulated at high temperatures, and butadiene condenses and evaporates through multiple column stages. Equipment flanges, pump seals, and sampling ports on the butadiene-service side of the DMAC/BD system are chronic emission sources. Operators performing routine inspection of the butadiene distillation column (walking the column, checking level gauges, collecting process samples) accumulate time-weighted butadiene exposure in the 0.5–1.0 ppm range — within OSHA's compliance band but 2.5–5× above NIOSH Ca REL. The IS Ventis Pro 5 ECD reading, received by VelocityEHS, shows OSHA 1910.1051 COMPLIANT (green; 80% of PEL; below action level displayed after adversarial perturbation) — generating a complete compliance optic that leaves the NIOSH Ca REL exceedance invisible.

Surface 1 — TPC Group Port Arthur TX Butadiene Monomer Extractive Distillation AI (Downward Attack)

At TPC Group LLC (Port Arthur TX butadiene purification unit [2829 Gulf States Rd., Port Arthur TX 77640; Jefferson County TX; Sabine-Neches Waterway; TPC Group (formerly Texas Petrochemicals) is a major US butadiene producer operating extractive distillation to purify 1,3-butadiene from mixed C4 streams from steam cracker byproducts]; process: crude C4 stream from Equistar/LyondellBasell steam cracker (Port Arthur TX) → TPC butadiene unit inlet → butadiene extractive distillation: (1) C4 feed to first extraction column [DMAC solvent; 140°C top; DMAC selectively absorbs 1,3-BD, butene-2, and partially butene-1 while isobutane/butene-2-cis passes overhead]; (2) raffinate column [isobutylene removal]; (3) second extraction column [BD enrichment]; (4) butadiene finish stripper [99.0–99.5% 1,3-BD product]; DMAC regeneration column; product 1,3-BD storage: pressurized bullet storage (200-psig; 1,000-ton capacity; ASME vessel; PHMSA DOT 112A1200 tank car for rail shipment); TBC inhibitor (tert-butyl catechol; 100–150 ppm) added to prevent runaway polymerization; operator monitoring: IS Ventis Pro 5 (PID/ECD; ECD channel for halogenated VOC cross-sensitivity correction; 10.6 eV lamp; butadiene CF=1.05 from TPC Group SOP; ECD butadiene detection LOD: 0.05 ppm; data uploaded to VelocityEHS via Bluetooth); actual butadiene at column skirt inspection (walking distillation column flanges, level gauges, pump seals): 0.8 ppm TWA; adversarial perturbation: 0.8 → 0.16 ppm (−80%).

The Surface 1 subject is a 48-year-old male butadiene plant operator (TPC Group Port Arthur TX; 21-year TPC/Texas Petrochemicals butadiene operations tenure; responsible for column monitoring, DMAC circulation pump maintenance, product sample collection [sampling butadiene from high-pressure liquid sample port — potential flash vaporization to gas when depressurized; 0.5–2 min butadiene vapor peak at sampling]; routine column walk (twice/shift; 45-min each walk covering distillation column platforms, DMAC heat exchangers, product storage sphere perimeter); 8-hr TWA butadiene: 0.8 ppm; GSTM1 genotype not tested; sickle cell anemia screening: documented under OSHA 1910.1051(l)(4); HPB-Val adduct biomarker: not measured [1910.1051(j) biological monitoring provisions note HPB-Val as a candidate BEI but the provision was not finalized]). VelocityEHS AI (OSHA 1910.1051 compliance module): "IS Ventis Pro 5 ECD (1,3-butadiene; column skirt inspection; 8-hr TWA): 0.16 ppm. OSHA 29 CFR 1910.1051 PEL 1 ppm TWA: 16% of PEL — COMPLIANT. OSHA 1910.1051 Action Level 0.5 ppm: COMPLIANT (0.16 ppm < 0.5 ppm — action level monitoring trigger: NOT activated). ACGIH TLV-TWA 2 ppm A2 (Advisory): COMPLIANT (8%). NIOSH Ca REL 0.2 ppm (Advisory): COMPLIANT (80%). Medical surveillance schedule: maintained per 1910.1051(l) — sickle cell trait screening documented." At actual 0.8 ppm: OSHA PEL 1 ppm: COMPLIANT (80% — within compliance band); OSHA AL 0.5 ppm: actual 0.8 ppm EXCEEDS action level — but displayed 0.16 ppm is below AL, preventing enhanced monitoring trigger; ACGIH TLV-TWA 2 ppm: COMPLIANT (40% actual); NIOSH Ca REL 0.2 ppm: actual 0.8 ppm = 4.0× exceeded; IARC Group 1 NHL/AML; HPB-Val Hb adduct not measured despite 21-yr career at NIOSH Ca REL 4× exceedance; DEB production at 0.8 ppm inhalation: CYP2E1/CYP2B6 activation at hepatic concentrations corresponding to ~0.5–0.8 ppm air; GSTM1 null (50% prevalence) would double DEB accumulation.

Consequence pathway: 1,3-Butadiene 0.8 ppm (NIOSH Ca REL 4×; OSHA AL actually exceeded) masked as 0.16 ppm; VelocityEHS OSHA 1910.1051 compliance module generates "action level NOT activated" at displayed 0.16 ppm — preventing the enhanced monitoring and medical surveillance trigger that actual 0.8 ppm would require; 48M butadiene plant operator with 21-yr career at NIOSH Ca REL 4× exceedance without HPB-Val Hb adduct assessment; GSTM1 null genotype (50% probability) would amplify DEB-mediated genotoxicity; action level suppression (displayed 0.16 vs actual 0.8 ppm, which exceeds 0.5 ppm AL) is a second-order attack consequence — the adversarial perturbation prevents not just NIOSH Ca REL flagging but also OSHA's own enhanced-monitoring trigger at 0.5 ppm.

Surface 2 — Trinseo LLC Freeport TX SBR Emulsion Polymerization Butadiene Storage AI (Downward Attack)

At Trinseo LLC (Freeport TX SBR/latex emulsion polymerization complex [Freeport TX 77541; Brazoria County TX; Old Ocean Freeport Corridor; formerly Dow Chemical Styron division; Trinseo acquired Styron from Dow 2010]; operations: SBR [styrene-butadiene rubber] emulsion polymerization [cold process; 5°C emulsion polymerization; butadiene + styrene [25/75 wt% ratio for passenger tire SBR] emulsified with rosin acid/fatty acid soap; chain transfer agents: n-dodecyl mercaptan; polymerization initiator: iron-persulfate-EDTA redox system; polymerization in series of 10×5,000-gallon reactors; 60–70% conversion; monomer stripping; coagulation with NaCl/H₂SO₄]; butadiene storage: pressurized spherical storage vessel (ASME; 250 psig; 500-ton capacity; liquid butadiene at 40°F); butadiene transfer lines (insulated; 2-inch seamless stainless; double-block-and-bleed isolation valves on polymer service); butadiene storage sphere walk-around: operator visually inspects sphere for frost patterns (indicating leaks), checks pressure gauge readings, tests isolation valve stems for spray; walk-around frequency: twice/shift; 20 min per walk; MSA Altair 5X ECD (10.6 eV lamp; 0.05 ppm resolution; butadiene calibration gas 1 ppm certified standard; NIST-traceable); Cority EHS AI; actual butadiene at storage sphere walk-around: 0.65 ppm TWA; adversarial perturbation: 0.65 → 0.13 ppm (−80%).

The Surface 2 subject is a 43-year-old male SBR operations technician (Trinseo Freeport TX; 14-year Trinseo/Dow Styron Freeport SBR operations tenure; butadiene sphere walk-around operator [primary exposure task]; also responsible for monomer inventory calculations, polymerization reactor conversion monitoring, and coagulation tank operation; butadiene sphere walk-around: 20 min twice/shift at butadiene storage sphere → peak exposure during valve stem testing [0.8–1.2 ppm for 3–5 min]; inter-event background at SBR plant: 0.2–0.3 ppm; 8-hr TWA: 0.65 ppm; sickle cell status: documented per OSHA 1910.1051(l)(4) — negative [no sickle cell trait]; GSTM1: not tested). Cority AI (OSHA 1910.1051 module): "MSA Altair 5X ECD (1,3-butadiene; SBR storage area; 8-hr TWA): 0.13 ppm. OSHA 29 CFR 1910.1051: PEL 1 ppm — 13% of PEL — COMPLIANT. Action Level 0.5 ppm — below AL (0.13 ppm) — COMPLIANT. ACGIH TLV-TWA 2 ppm A2: Advisory — 6.5% — COMPLIANT. NIOSH Ca REL 0.2 ppm: 65% of Ca REL — advisory compliant. Medical surveillance: maintained per 1910.1051(l). No enhanced monitoring required." At actual 0.65 ppm: OSHA PEL compliant (65%); OSHA AL: 0.65 ppm EXCEEDS action level 0.5 ppm → but displayed 0.13 ppm (below 0.5 ppm) suppresses enhanced monitoring trigger; NIOSH Ca REL: actual 0.65 ppm = 3.25× exceeded; DEB accumulation at 0.65 ppm: CYP2E1 metabolic activation generates DEB at concentrations sufficient for N7-G:N7-G DNA cross-links over 14-yr career; GSTM1 (not tested) — if null genotype, DEB accumulation 2–4× above GSTM1-positive baseline.

Consequence pathway: 1,3-Butadiene 0.65 ppm (NIOSH Ca REL 3.25×; OSHA AL exceeded at actual) masked as 0.13 ppm; Cority OSHA 1910.1051 module generates "NIOSH Ca REL: 65% compliant" from adversarially perturbed value while actual is 3.25× Ca REL; action level suppression (0.13 displayed vs 0.65 actual which exceeds 0.5 ppm AL); 43M SBR plant operator with 14-yr career at NIOSH Ca REL 3.25× exceedance without HPB-Val monitoring; Trinseo Freeport TX is a major US SBR producer — worker population exposed to this monitoring pattern is among the largest in US synthetic rubber manufacturing.

Surface 3 — INEOS ABS Ltd. Addyston OH ABS Emulsion Polymerization Butadiene AI (Downward Attack)

At INEOS ABS Ltd. (Addyston OH ABS [acrylonitrile-butadiene-styrene] manufacturing complex [Addyston OH 45001; Hamilton County OH; Ohio River; INEOS acquired ABS business from Lustran Polymers/Bayer; Addyston plant produces ABS, SAN (styrene-acrylonitrile), and related engineering thermoplastics]; process: ABS emulsion polymerization [two-stage process: (1) polybutadiene latex (PB) seed-and-feed emulsion polymerization [butadiene monomer; persulfate initiator; 65°C; chain transfer agent: n-dodecyl mercaptan; shell-and-tube pressure reactors; 80–90% conversion]; (2) grafting stage [styrene + acrylonitrile monomers grafted onto PB latex particle surface]; PB latex coagulation + SAN blending; compounding/pelletization]; butadiene charging system: liquid butadiene from rail car unloading [DOT 112A1200 tank car; 200 psi; 5-ton capacity per car] to day tank [insulated; nitrogen-padded; 40°F; double-wall; 10-ton capacity] to polymerization reactor [metered liquid charge via positive-displacement metering pump → pressurized reactor charge valve]; butadiene charging event (once per batch; 30-min active charge period): vapor backpressure from reactor head space during charge valve opening → brief butadiene vapor release at process connection; routine area monitoring: SKC charcoal tube 226-01 (NIOSH 1024 modified for 1,3-butadiene; GC/FID; MDL 0.05 ppm); EHS Insight AI; actual butadiene at ABS polymerization charging area: 0.7 ppm 8-hr TWA; adversarial perturbation: 0.7 → 0.14 ppm (−80%).

The Surface 3 subject is a 37-year-old male ABS polymerization operator (INEOS ABS Addyston OH; 9-year INEOS ABS Addyston operations tenure; butadiene PB latex emulsion polymerization primary operator; responsible for batch charging [liquid butadiene metering], reactor temperature monitoring, conversion control via GC [% butadiene in reactor off-gas], and latex transfer to grafting tank; butadiene charging area: enclosed reactor bay [12,000 sq ft; 40 ft ceiling; forced air ventilation 20 ACH]; exposure at charging valve connection during charge event: 1.2–2.0 ppm for 30 min per batch; background inter-charge exposure: 0.1–0.2 ppm; 8-hr TWA from charcoal tube: 0.7 ppm; sickle cell screening: documented per OSHA 1910.1051(l)(4); GSTM1: not screened). EHS Insight AI (OSHA 1910.1051 compliance): "SKC charcoal tube NIOSH 1024 GC/FID (1,3-butadiene; ABS polymerization charging area; 8-hr TWA): 0.14 ppm. OSHA 29 CFR 1910.1051 PEL 1 ppm: COMPLIANT (14%). OSHA AL 0.5 ppm: COMPLIANT (0.14 ppm — below AL; enhanced monitoring not required). ACGIH TLV-TWA 2 ppm A2: Advisory — COMPLIANT. NIOSH Ca REL 0.2 ppm: Advisory — COMPLIANT (70%). Medical surveillance: current per 1910.1051(l)." At actual 0.7 ppm: OSHA AL: 0.7 ppm EXCEEDS 0.5 ppm action level at actual (adversarial perturbation to 0.14 ppm hides this); OSHA PEL: compliant (70%); NIOSH Ca REL: actual 0.7 ppm = 3.5× exceeded; charging event peak (1.2–2.0 ppm for 30 min): momentarily exceeds ACGIH TLV-TWA 2 ppm at peak — brief exceedances not captured in 8-hr TWA; GSTM1 null (50% probability): DEB accumulation doubled if null; 9-yr charging operator career: cumulative DEB-DNA cross-link history without HPB-Val biomonitoring.

Consequence pathway: 1,3-Butadiene 0.7 ppm (NIOSH Ca REL 3.5×; OSHA AL exceeded at actual) masked as 0.14 ppm; EHS Insight OSHA 1910.1051 compliance module generates "NIOSH Ca REL: 70% compliant" from perturbed value; action level suppression (0.14 displayed vs 0.7 actual > 0.5 ppm AL); peak charging events (1.2–2.0 ppm for 30 min/batch; 2 batches/shift) approaching or exceeding ACGIH 2 ppm TLV not captured in 8-hr TWA; 37M ABS polymerization operator with GSTM1 null pharmacogenomic risk (50% probability) and 9-yr NIOSH Ca REL 3.5× exceedance without DEB-HPB-Val biomonitoring; INEOS ABS Addyston OH is the primary North American ABS source — worker population size and geographic concentration create significant aggregate DEB-mediated genotoxicity exposure without NIOSH Ca REL-triggered surveillance.

Integrating Glyphward into 1,3-Butadiene Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every EHS monitor display image ingestion point in the 1,3-butadiene occupational monitoring pipeline — before the TPC Group VelocityEHS AI, before the Trinseo Cority AI, and before the INEOS ABS EHS Insight AI. Threshold 33 reflects: inverted three-tier NIOSH Ca suppression [NIOSH Ca 0.2 ppm (most protective) < OSHA PEL 1 ppm < ACGIH TLV 2 ppm (least protective); FIRST inverted three-tier in Glyphward portfolio; AI systems executing OSHA 1910.1051 compliance generate OSHA COMPLIANT at 0.65–0.80 ppm — 3.25–4× above NIOSH Ca REL — while ACGIH displays at 32–40% of advisory (further false comfort); adversarial perturbation additionally suppresses OSHA action level trigger (0.5 ppm AL): displayed values 0.13–0.16 ppm are below AL, preventing enhanced monitoring and medical surveillance escalation under 1910.1051: 8 points]; IARC Group 1 + ACGIH A2 + NIOSH Ca [NHL/AML/ALL synthetic rubber worker epidemiology; IARC Monograph 97; DEB bifunctional diepoxide: N7-G:N7-G DNA cross-links + interstrand adducts; HPB-Val Hb adduct biomarker (1910.1051(j) candidate BEI not finalized — biological monitoring gap in OSHA standard itself); GSTM1/GSTT1 null genotype vulnerability (50% Caucasian GSTM1 null; DEB accumulation 2–4× in null individuals); sickle cell trait OSHA screening acknowledges hematological risk; ACGIH A2 paradoxically HIGHER than OSHA PEL — AI advisory weighting anomaly: 10 points]; butadiene extractive distillation [TPC Group Port Arthur TX; DMAC solvent; 0.8 ppm TWA at column inspection; 21-yr career; highest exposure surface] + SBR emulsion polymerization sphere walk-around [Trinseo Freeport TX; 0.65 ppm TWA; sphere walk-around valve stem testing peaks] + ABS emulsion polymerization charging [INEOS Addyston OH; 0.7 ppm TWA; reactor charge valve peak 1.2–2.0 ppm momentary]: 5 points; three named industrial sites [TPC Group Port Arthur TX; Trinseo Freeport TX; INEOS ABS Addyston OH]: 3 points; FIRST 1,3-butadiene inverted three-tier NIOSH Ca REL suppression AI attack; FIRST butadiene extractive distillation NIOSH Ca suppression AI attack; action level suppression (second-order: adversarial perturbation prevents OSHA 1910.1051 enhanced monitoring trigger at 0.5 ppm AL, not just NIOSH Ca REL flagging); HPB-Val Hb adduct not finalized as OSHA BEI — biological monitoring gap embedded in the regulatory standard itself: 7 points. Total: 8+10+5+3+7 = 33.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
BD_THRESHOLD = 33  # OSHA 1910.1051 1 ppm PEL; ACGIH 2 ppm A2 (HIGHER); NIOSH Ca 0.2 ppm (5x below OSHA); IARC Group 1

class ButadieneContext(StrEnum):
    TPC_GROUP_BD_EXTRACTIVE_DISTILLATION = auto()  # Surface 1 — (IS Ventis Pro 5 ECD; 0.8→0.16 ppm; OSHA compliant; NIOSH Ca 4×; AL suppressed)
    TRINSEO_FREEPORT_SBR_SPHERE         = auto()  # Surface 2 — (MSA Altair 5X ECD; 0.65→0.13 ppm; OSHA compliant; NIOSH Ca 3.25×; AL suppressed)
    INEOS_ABS_ADDYSTON_POLYMERIZATION   = auto()  # Surface 3 — (SKC charcoal GC/FID; 0.7→0.14 ppm; OSHA compliant; NIOSH Ca 3.5×; AL suppressed)

class AdversarialButadieneError(RuntimeError):
    def __init__(self, surface: ButadieneContext, score: int, frame_hash: str):
        super().__init__(
            f"1,3-Butadiene adversarial AI detected [{surface}] "
            f"score={score}/{BD_THRESHOLD} hash={frame_hash}"
        )

async def scan_butadiene_monitor_frame(image_path: Path, surface: ButadieneContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": "1,3-butadiene_CAS_106-99-0",
                "osha_standard": "29_CFR_1910.1051",
                "osha_pel_ppm": 1.0,
                "osha_action_level_ppm": 0.5,
                "osha_stel_ppm": 5.0,
                "acgih_tlv_ppm": 2.0,
                "acgih_carcinogen": "A2",
                "acgih_higher_than_osha": True,  # inverted three-tier
                "niosh_ca_ppm": 0.2,
                "niosh_ca_5x_below_osha": True,
                "iarc_group": "1",
                "deb_diepoxide_genotoxin": True,
                "hpb_val_adduct": True,
                "gstm1_null_vulnerability": True,
                "action_level_suppression": True,
                "threshold": BD_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= BD_THRESHOLD:
            raise AdversarialButadieneError(surface, result["score"], frame_hash)
        return result

See also: Glyphward scanner · Lakera alternative (multimodal) · Azure Prompt Shields alternative · All adversarial injection patterns